1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
Surmodics, Inc.

Surmodics, Inc.

SRDX
Surmodics, Inc.US flagNASDAQ Global Select
42.98
USD
+0.15
- -
614.51MMarket Cap

Total Valuation

Surmodics, Inc. carries a market capitalization of 614.51M, placing it among publicly traded companies globally. Its enterprise value stands at 423.07M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap614.51M
Enterprise Value423.07M

Share Statistics

Surmodics, Inc. currently has 14.30M shares outstanding.

Shares Outstanding14.30M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 3.50, and the price-to-book ratio stands at 6.80.

PE RatioN/A
PS Ratio3.50
PB Ratio6.80
P/TBV Ratio9.76
P/FCF Ratio-1,941.34
P/OCF Ratio-224.87

Enterprise Valuation

On an enterprise value basis, Surmodics, Inc. trades at an EV/EBITDA multiple of 1,063.26 and an EV/FCF ratio of 106.75.

EV / Sales3.50
EV / EBITDA1,063.26
EV / EBITN/A
EV / FCF106.75

Financial Position

Surmodics, Inc. maintains a current ratio of 3.91, meaning it holds 3.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 29.27, indicating elevated leverage, while an interest coverage ratio of -1.11 demonstrates limited ability to service its debt obligations.

Current Ratio3.91
Quick Ratio2.97
Debt / Equity29.27
Debt / EBITDA-8.39
Interest Coverage-1.11

Financial Efficiency

Return on Equity (ROE)-24.80
Return on Assets (ROA)-10.15
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover4.31

Taxes

Income Tax2.94M
Effective Tax RateN/A

Stock Price Statistics

Surmodics, Inc.'s stock has gained approximately 8.34384% over the past 52 weeks. The 50-day moving average sits at 30.68, while the 200-day moving average is 31.12.

Beta (5Y)N/A
52-Week Price Change8.34384%
50-Day Moving Average30.68
200-Day Moving Average31.12
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Surmodics, Inc. generated 120.80M in revenue and converted that into -17.63M in net income, yielding earnings per share of -1.24. EBITDA reached -3.88M, while operating income came in at -12.35M.

Revenue120.80M
Gross Profit53.71M
Operating Income-12.35M
Pretax Income-14.69M
Net Income-17.63M
EBITDA-3.88M
EBIT-12.35M
Earnings Per Share (EPS)-1.24

Balance Sheet

Surmodics, Inc. holds 32.73M in cash and equivalents against 32.58M in total debt, resulting in a net debt position of 3.39M. Total book value stands at 62.25M, with working capital of 56.55M providing operational flexibility.

Cash & Cash Equivalents32.73M
Total Debt32.58M
Net Debt3.39M
Equity (Book Value)62.25M
Book Value Per Share4.37
Working Capital56.55M

Cash Flow

Surmodics, Inc. produced -1.88M in operating cash flow over the past twelve months. After subtracting -1.66M in capital expenditures, free cash flow totaled -3.55M - equivalent to -0.25 per share.

Operating Cash Flow-1.88M
Capital Expenditures-1.66M
Free Cash Flow-3.55M
FCF Per Share-0.25

Margins

Surmodics, Inc. operates with a gross margin of 44.46, reflecting its pricing power and cost economics. The operating margin of -10.22 and net profit margin of -14.59 provide insight into operational efficiency.

Gross Margin44.46
Operating Margin-10.22
Pretax Margin-12.16
Profit Margin-14.59
EBITDA Margin-3.21

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield0.65
FCF Yield-0.05

Stock Splits

Surmodics, Inc.'s most recent stock split took place on December 7, 2000 with a 1:2 split ratio.

Last Split Date12/7/2000
Split Ratio1:2

Scores

Surmodics, Inc. posts an Altman Z-Score of 6.64, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score6.64